Items Tagged ‘CHART-1 Trial’

October 29, 2020

Long-term safety, benefits of stem therapy for heart failure

By Susan Buckles Susan Buckles (@susanbuckles)

The largest regenerative medicine clinical trial to date for heart failure finds stem cell therapy is safe over the long term and benefits patients with advanced left ventricular enlargement. This multinational research, co-led by Andre Terzic, M.D., Ph.D., director of Mayo Clinic’s Center for Regenerative Medicine, and published in ESC Heart Failure, offers guidance in […]

View full entry

Tags: cardiac regeneration, cardiopoietic stem cells, CHART-1 Trial, Dr. Andre Terzic, heart disease, Mayo Clinic Center for Regeneration, stem cell therapy

Contact Us · Privacy Policy